Granite Point Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,626,667
| Closed | -$1.12M | – | 203 |
|
|
2020
Q4 | $1.12M | Buy |
1,626,667
+1,526,667
| +1,527% | +$1.05M | 0.06% | 88 |
|
|
2020
Q3 | $225K | Sell |
100,000
-800,000
| -89% | -$1.8M | 0.01% | 105 |
|
|
2020
Q2 | $3.22M | Buy |
900,000
+200,000
| +29% | +$716K | 0.16% | 29 |
|
|
2020
Q1 | $2.66M | Sell |
700,000
-550,000
| -44% | -$2.09M | 1.5% | 21 |
|
|
2019
Q4 | $3.76M | Buy |
+1,250,000
| New | +$3.76M | 0.59% | 10 |
|